External-Beam Radiation Therapy For Localized Prostate Cancer Linked To Bladder, Lung And Colorectal Cancer

Patients undergoing external-beam radiation therapy (EBRT) for localized prostate cancer may be at an increased risk for secondary malignancy, according to a study from researchers in Canada, Italy and the United States presented during the Annual Scientific Meeting of the American Urological Association (AUA) in Orlando. Researchers will present data to reporters during a special press conference on May 19, 2008 at 1:30 p.m.

These findings have significant implications for men evaluating treatment options for localized prostate cancer.

source: Medical News Today